Evidence map›Paper›PMID 32418038›Full record

ArticleClinical rheumatology2020

Juvenile idiopathic arthritis in Southeast Asia: the Singapore experience over two decades.

Manasita Tanya, Kai Liang Teh, Lena Das, Sook Fun Hoh, Xiaocong Gao, Thaschawee Arkachaisri

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Disease Damage in Juvenile Idiopathic Arthritis.Indian journal of pediatrics · 2025
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Spondyloarthritides: Theories and beyond.Frontiers in pediatrics · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Manasita TanyaDepartment of Pediatric Subspecialties, Rheumatology and Immunology Service, KK Women's and Children's Hospital, Kampong Java, Singapore.
Kai Liang TehDepartment of Pediatric Subspecialties, Rheumatology and Immunology Service, KK Women's and Children's Hospital, Kampong Java, Singapore.
Lena DasDepartment of Pediatric Subspecialties, Rheumatology and Immunology Service, KK Women's and Children's Hospital, Kampong Java, Singapore.
Sook Fun HohDivision of Nursing, KK Women's and Children's Hospital, Kampong Java, Singapore.
Xiaocong GaoDivision of Nursing, KK Women's and Children's Hospital, Kampong Java, Singapore.
Thaschawee ArkachaisriDepartment of Pediatric Subspecialties, Rheumatology and Immunology Service, KK Women's and Children's Hospital, Kampong Java, Singapore. thaschawee.arkachaisri@singhealth.com.sg.ORCID https://orcid.org/0000-0002-1387-1169
KK Women's and Children's Hospital · SGSingHealth · SG

Funding

FUNCTION OF FCERI ON EPIDERMAL LANGERHANS CELLSK08AR002011 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI BORKOWSKI, TERESA A · 1997 to 2001
$252k
International Leagues of Associations for Rheumatologists ILAR2011National Arthritis Foundation of Singapore NAF2011
6 · The paper itself

Abstract

objectivesTo examine the clinical characteristics, treatment and outcomes of juvenile idiopathic arthritis (JIA) patients evaluated in Singapore and compare those with reports elsewhere.

methodsPatients with JIA were recruited from our Singapore pediatric rheumatology registry from January 1997 to December 2015. Demographic, clinical, treatment, and outcome data were retrospectively collected. Nonparametric statistics were used to describe the data. Chi-squared, Mann-Whitney U, or Kruskal-Wallis tests were applied to compare differences between groups where appropriate. Multivariate logistic regression analyses were used to identify predictors for clinical parameters.

resultsTwo hundred eighty-seven JIA patients with 60.6% males of predominantly Chinese descent were included in the study. The median onset age was 9 years (IQR 5.3-12.6), and the median follow-up duration was 30.1 months (IQR 9.1-61.7). Enthesitis-related arthritis (ERA, 32.8%) followed by persistent oligoarthritis (31.0%) was the most common. Elbow or ankle involvement predicted oligoarthritis extension (OR 15.8 (95% CI: 2.3-108.3, p = 0.005), 8.1 (95% CI: 1.5-45.3, p = 0.017)). JIA-associated uveitis was rare (2.8%) which paralleled the less common positive-ANA rate. Majority of our ERA patients had HLA-B27 (79.8%), together with older age predicted sacroiliitis (OR 4.7 (95% CI: 2.0-11.1, p < 0.05), OR 1.2 (95% CI: 1.1-1.3, p = 0.002)). TMJ involvement was under-reported. Methotrexate remained the most common DMARD used, but 36% of patients required biologics for which ERA and polyarthritis were the majority. Joint damage was rare.

conclusionThis study highlights geographical and ethnic differences in JIA epidemiology. Compared with reports elsewhere, our JIA population had many unique findings and good functional outcomes requiring regional study validation. Key points • ERA is the most prominent JIA subtype in Singapore with high prevalence of HLA-B27. • JIA-associated uveitis is rare in SEA and is not associated with ANA or JIA-subtypes. • Elbow and/or ankle involvement at presentation is associated with oligoarthritis extension in our JIA cohort.

Indexed as

Arthritis, JuvenileUveitisAgedChildFemaleHLA-B27 AntigenHumansInfantMaleRetrospective StudiesSingaporeHLA-B27 AntigenEnthesitis-related arthritisHLA-B27Juvenile idiopathic arthritisSingaporeSoutheast AsiaTreatment

Identifiers

PMID32418038
OpenAlexW3024307056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.